Pancreatic Cancer Research

ResearcherUniversity of LiverpoolActive in the last 2 years

Olusola Olusesan Faluyi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6710-2210; OpenAlex author ID A5033086853. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

2017: 2 papers · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. Real-world outcomes following adjuvant chemotherapy for resected pancreatic cancer in a centralised oncology service. Co-author DOI 10.1038/s41416-026-03341-0↗
  2. Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial. Co-author DOI 10.1200/jco.24.01118↗
  3. Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. Co-author DOI 10.1001/jamasurg.2019.3337↗
  4. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-lab… Co-author DOI 10.1016/s0140-6736(16)32409-6↗
  5. Advanced pancreatic adenocarcinoma outcomes with transition from devolved to centralised care in a regional Cancer Centre. Co-author DOI 10.1038/bjc.2016.406↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Paula Ghaneh · 4 shared papers, 2017–2026 · strength 0.53
  2. John P. Neoptolemos · 4 shared papers, 2017–2026 · strength 0.53
  3. Christopher Michael Halloran · 4 shared papers, 2017–2026 · strength 0.53
  4. Daniel H. Palmer · 4 shared papers, 2017–2025 · strength 0.35
  5. Gary Middleton · 3 shared papers, 2017–2025 · strength 0.27
  6. Yuk Ting Ma · 3 shared papers, 2017–2025 · strength 0.27
  7. Paul J. Ross · 3 shared papers, 2017–2025 · strength 0.27
  8. Bengt L. G. Glimelius · 3 shared papers, 2017–2025 · strength 0.27
  9. Thilo Hackert · 3 shared papers, 2017–2025 · strength 0.27
  10. Tim Meyer · 3 shared papers, 2017–2025 · strength 0.27
  11. Pascal R. Hammel · 3 shared papers, 2017–2025 · strength 0.27
  12. David Cunningham · 3 shared papers, 2017–2025 · strength 0.27
  13. Harpreet Singh Wasan · 3 shared papers, 2017–2025 · strength 0.27
  14. Juan W. Valle · 3 shared papers, 2017–2025 · strength 0.27
  15. Martyn Charles Stott · 1 shared paper, 2026 · strength 0.26
  16. Jessica Hale · 1 shared paper, 2026 · strength 0.26
  17. Daniel H. Palmer · 1 shared paper, 2026 · strength 0.26
  18. Peter J. Bailey · 1 shared paper, 2025 · strength 0.17
  19. Christoph Springfeld · 1 shared paper, 2025 · strength 0.17
  20. Christoph W. Michalski · 1 shared paper, 2025 · strength 0.17
  21. Alan Anthoney · 2 shared papers, 2017–2019 · strength 0.10
  22. Markus Wolfgang Büchler · 2 shared papers, 2017–2019 · strength 0.10
  23. Derek A O'Reilly · 2 shared papers, 2017–2019 · strength 0.10
  24. Jakob Robert Izbicki · 2 shared papers, 2017–2019 · strength 0.10
  25. Robert Peter Jones · 1 shared paper, 2019 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.